Glaxo
- C07 - Betabloqueantes
- TRANDATE film-coated tablet 100 mg
- TRANDATE solution for injection 100 mg/20 ml
- D01 - Antifúngicos para uso dermatológico
- GRISOVIN tablet 125 mg
- GRISOVIN tablet 500 mg
- D06 - Antibióticos y quimioterápicos para uso dermatológico
- BACTROBAN ointment 2%
- D07 - Preparados dermatológicos con corticosteroides
- CUTIVATE cream 0.05%
- CUTIVATE ointment 0.005%
- J01 - Antibacterianos para uso sistémico
- CEPOREX capsule, hard 250 mg
- CEPOREX capsule, hard 500 mg
- CEPOREX oral drops, solution 100 mg/ml
- CEPOREX syrup 125 mg/5 ml
- CEPOREX syrup 250 mg/5 ml
- L01 - Antineoplásicos
- TYKERB film-coated tablet 250 mg
- N01 - Anestésicos
- ULTIVA powder for solution for injection 1 mg
- ULTIVA powder for solution for injection 2 mg
- ULTIVA powder for solution for injection 5 mg
- N02 - Analgésicos
- IMIGRAN solution for injection 6 mg/0.5 ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- NIQUITIN MINT lozenge 2 mg
- NIQUITIN MINT lozenge 4 mg
- R01 - Preparaciones nasales
- BACTROBAN nasal ointment 2%
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLIXOTIDE DISKUS inhalation powder 100 µg
- FLIXOTIDE DISKUS inhalation powder 250 µg
- FLIXOTIDE DISKUS inhalation powder 50 µg
- FLIXOTIDE DISKUS inhalation powder 500 µg
- FLIXOTIDE inhalation powder 25 µg
- FLIXOTIDE inhalation powder 250 µg
- SERETIDE DISKUS inhalation powder 50 µg+100 µg
- SERETIDE DISKUS inhalation powder 50 µg+250 µg
- SERETIDE DISKUS inhalation powder 50 µg+500 µg